on 16 Jun 2020
Last Applicant/ Owned by
Viaduktstrasse 8
Basel
CH
4051
Serial Number
88361384 filed on 28th Mar 2019
Registration Number
6077704 registered on 16th Jun 2020
Correspondent Address
Allison Strickland Ricketts
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and condiRead More
(Based on 44(e)) Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials
Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
No 88361384
No Service Mark
No ENZT 1903673
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 16th Jun 2020 | REGISTERED-PRINCIPAL REGISTER |
| 31st Mar 2020 | PUBLISHED FOR OPPOSITION |
| 31st Mar 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 11th Mar 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Feb 2020 | ELECTRONIC RECORD REVIEW COMPLETE |
| 07th Feb 2020 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 04th Feb 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Jan 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 26th Jan 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Jan 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
